Lack of MHC class II molecules favors CD8<sup>+</sup> T-cell infiltration into tumors associated with an increased control of tumor growth.

Chaoul, Nada; Tang, Alexandre; Desrues, Belinda; Oberkampf, Marine; Fayolle, Catherine; Ladant, Daniel; Sainz-Perez, Alexander; Leclerc, Claude

Lack of MHC class II molecules favors CD8⁺ T-cell infiltration into tumors associated with an increased control of tumor growth.

Chaoul, Nada; Tang, Alexandre; Desrues, Belinda; Oberkampf, Marine; Fayolle, Catherine; Ladant, Daniel; Sainz-Perez, Alexander; Leclerc, Claude.

Afiliação

Chaoul N; Département d'immunologie, Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, France.
Tang A; Inserm U1041, Paris, France.
Desrues B; Département d'immunologie, Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, France.
Oberkampf M; Inserm U1041, Paris, France.
Fayolle C; Département d'immunologie, Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, France.
Ladant D; Inserm U1041, Paris, France.
Sainz-Perez A; Département d'immunologie, Institut Pasteur, Unité de Régulation Immunitaire et Vaccinologie, Equipe Labellisée Ligue Contre le Cancer, France.
Leclerc C; Inserm U1041, Paris, France.

Oncoimmunology ; 7(3): e1404213, 2018.

Article em En | MEDLINE | ID: mdl-29399403

Palavras-chave

CD8+ T-cells; immunosuppression; immunotherapy; regulatory T-cells; tumor microenvironment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2018 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google